Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.The company's compounds aid in the treatment of non-functioning pituitary adenoma using a dopamine-somatostatin chimeric molecule that has the potential to shrink or halt tumor growth, providing patients with effective treatment for rareneuroendocrine tumors and endocrine diseases.

Biotechnology

Health Care

Pharmaceutical

Tiburio Therapeutics

Tiburio Therapeutics' headquarters in Cambridge, MA, United States

Description

People

Jobs